Franklin I Aigbirhio Selected Research

1- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- one

1/2022	Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
1/2020	11C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franklin I Aigbirhio Research Topics

Disease

9	Neuroinflammatory Diseases 12/2021 - 01/2018
9	Cognitive Dysfunction 01/2021 - 01/2016
8	Dementia (Dementias) 01/2022 - 07/2011
8	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 07/2011
8	Stroke (Strokes) 10/2017 - 01/2005
7	Down Syndrome (Down's Syndrome) 01/2022 - 07/2011
7	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 01/2017
7	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2021 - 01/2017
7	Hypoxia (Hypoxemia) 01/2017 - 07/2006
6	Atrophy 01/2022 - 01/2019
6	Tauopathies 01/2022 - 01/2017
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2019 - 04/2007
5	Ischemic Stroke 01/2018 - 01/2005
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2015 - 04/2009
4	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 10/2018
4	Infarction (Infarctions) 03/2016 - 03/2013
3	Corticobasal Degeneration 01/2022 - 10/2020
3	Inflammation (Inflammations) 01/2021 - 03/2016
3	Ischemia 01/2020 - 01/2016
3	Necrosis 12/2018 - 04/2007
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 01/2008
3	Craniocerebral Trauma (Head Injury) 07/2011 - 06/2002
2	Parkinson Disease (Parkinson's Disease) 07/2021 - 01/2021
2	Disease Progression 01/2021 - 01/2017
2	Brain Hypoxia (Cerebral Hypoxia) 10/2017 - 04/2007
2	Hyperoxia 01/2017 - 01/2008
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2015 - 05/2014
2	Nervous System Diseases (Neurological Disorders) 05/2015 - 06/2013
2	Amyloid angiopathy 01/2015 - 01/2014
2	Cerebral Hemorrhage 01/2015 - 05/2014
1	Cerebral Cortical Thinning 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Intracranial Hypertension 01/2020
1	Mood Disorders (Mood Disorder) 01/2019
1	Asymptomatic Diseases 01/2019
1	Primary Progressive Aphasia 10/2018
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2017
1	Proteostasis Deficiencies 01/2017
1	Hyperaldosteronism (Conn Syndrome) 11/2016
1	Cushing Syndrome 11/2016
1	Adrenocortical Carcinoma 11/2016
1	Breast Neoplasms (Breast Cancer) 06/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2013
1	Gliosis 03/2013

Drug/Important Bio-Agent (IBA)

20	Amyloid (Amyloid Fibrils)IBA 01/2022 - 07/2011
12	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2008
10	Oxygen (Dioxygen)IBA 01/2020 - 06/2002
8	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2022 - 07/2011
6	LigandsIBA 07/2021 - 03/2011
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
5	fluoromisonidazoleIBA 10/2017 - 04/2007
4	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2021 - 01/2018
4	Methylphenidate (Ritalin)FDA LinkGeneric 03/2015 - 04/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2002
2	1- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- oneIBA 01/2022 - 01/2020
2	SynucleinsIBA 07/2021 - 01/2021
2	tau Proteins (tau Protein)IBA 01/2021 - 12/2020
2	PK 11195 (PK11195)IBA 12/2020 - 01/2020
2	Carbon DioxideIBA 01/2020 - 06/2002
2	Amyloid beta-PeptidesIBA 12/2019 - 01/2019
2	CarbonIBA 01/2014 - 07/2011
2	Dopamine (Intropin)FDA LinkGeneric 11/2013 - 03/2011
2	Therapeutic UsesIBA 11/2013 - 07/2013
2	Pharmaceutical PreparationsIBA 04/2009 - 09/2008
1	splenotritin (TP3)IBA 01/2022
1	LipopolysaccharidesIBA 12/2021
1	Indicators and Reagents (Reagents)IBA 07/2021
1	Polytetrafluoroethylene (Teflon)FDA Link 04/2020
1	alpha-SynucleinIBA 01/2020
1	TRAM 34IBA 10/2019
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2019
1	C-Reactive ProteinIBA 12/2018
1	Macrophage Colony-Stimulating FactorIBA 12/2018
1	CytokinesIBA 12/2018
1	neuromelaninIBA 10/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2018
1	Monoamine Oxidase (MAO)IBA 10/2018
1	Phospholipases (Phospholipase)IBA 01/2018
1	Protein AggregatesIBA 01/2017
1	platinum oxideIBA 01/2017
1	metomidateIBA 11/2016
1	Hormones (Hormone)IBA 11/2016
1	Glycogen Synthase Kinase 3IBA 05/2015
1	Glycogen Synthase (Synthase I)IBA 05/2015
1	TritiumIBA 01/2014
1	AutoreceptorsIBA 11/2013
1	CationsIBA 06/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2013
1	triphenylphosphoniumIBA 06/2013
1	Adenosine Triphosphate (ATP)IBA 06/2013
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2013
1	ThiosemicarbazonesIBA 04/2013
1	NitroimidazolesIBA 04/2013

Therapy/Procedure

9	Therapeutics 01/2020 - 07/2006
1	Immunomodulation 01/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Thrombectomy 01/2018
1	Electrocoagulation (Electrocautery) 04/2013
1	Surgical Instruments (Clip) 03/2013